http://www.newsweek.com/omicron-covid-variant-vaccines-pfizer-moderna-johnson-johnson-1657299

The Omicron variant poses significant—but incomplete—resistance to existing COVID vaccines, studies show, and boosters may help greatly.

Over recent days laboratory studies have been published providing some early data on how well the Pfizer vaccine performs against Omicron.